Analysts' recommendations: Avinger, Inc.

21/04/23	HC Wainwright Starts Avinger at Buy With $1.60 Price Target	MT
11/05/22	B. Riley Lowers Avinger's Price Target to $9 from $11, Keeps Buy Rating	MT
18/03/22	B. Riley Adjusts Avinger's Price Target to Post-Split $11 from $40, Expects Omicron Impact Late in Q4, Into Q1; Keeps Buy Rating	MT
29/06/21	AVINGER : B. Riley Starts Avinger at Buy with $2.50 PT, Says Well-Positioned to Execute on Growth Strategy	MT

More recommendations

Managers and Directors: Avinger, Inc.

Manager	Title	Age	Since
Karina Yamamoto CEO	Chief Executive Officer	-	-
Thomas Davis CTO	Chief Tech/Sci/R&D Officer	-	04/08/2024

More insiders

Avinger Inc is a United States-based company. The Company operates as a medical device company that designs, manufactures, and sells image-guided, catheter-based systems for treating peripheral artery disease (PAD). Its products are used by interventional cardiologists, vascular surgeons, and interventional radiologists in the United States and select international markets and are based on its Lumivascular platform, a system that uses optical coherence tomography (OCT) for real-time visualization inside arteries. Its products includes the Lightbox imaging console, Ocelot and Tigereye catheters for crossing blockages, and Pantheris for removing plaque.

Employees

Sector

Advanced Medical Equipment & Technology

More about the company

Income Statement and Estimates

More financial data

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

United-States

Canada

Market Closed - Nasdaq Other stock markets 21:00:00 14/02/2025 GMT			5-day change	1st Jan Change
0.4740 ^USD	-20.74%		-.--%	-

19/02/25	Avinger, Inc.(NasdaqCM:AVGR) dropped from S&P TMI Index	CI
16/02/25	Avinger, Inc.(NasdaqCM:AVGR) dropped from NASDAQ Composite Index	CI

Market Cap	2.71M 2.35M 2.19M 2.01M 3.8M 258M 3.86M 25.82M 10.13M 129M 10.17M 9.94M 431M	P/E 2022	-0.25x	P/E 2023	-0.19x
Enterprise Value	12.83M 11.15M 10.38M 9.53M 17.99M 1.22B 18.27M 122M 48.01M 610M 48.17M 47.12M 2.04B	EV / Sales 2022	1.19x	EV / Sales 2023	1.78x
Free-Float	88.44%	Yield 2022 *	-	Yield 2023	-

19/02/25	Avinger, Inc.(NasdaqCM:AVGR) dropped from S&P TMI Index	CI
16/02/25	Avinger, Inc.(NasdaqCM:AVGR) dropped from NASDAQ Composite Index	CI
10/02/25	Avinger Inc Terminated Employment Of Each Of Jeffrey M. Soinski, Co's CEO And Nabeel Subainati, Vice President, Finance	RE
10/02/25	Avinger, Inc. Announces Termination of the Employment of Jeffrey M. Soinski, Chief Executive Officer	CI
10/02/25	Avinger, Inc. Announces Executive Changes	CI
24/12/24	Wall Street Set to Open Mixed Tuesday Ahead of Holiday Break	MT
24/12/24	US Futures Tread Water Ahead of Holiday Break	MT
23/12/24	Iberdrola Completes Merger with Avangrid	MT
07/11/24	Avinger, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024	CI
07/11/24	Earnings Flash (AVGR) AVINGER Reports Q3 Loss $-1.82	MT
07/11/24	Earnings Flash (AVGR) AVINGER Posts Q3 Revenue $1.7M	MT
07/11/24	Avinger, Inc., Q3 2024 Earnings Call, Nov 07, 2024
04/10/24	Wall Street Set to Open Higher Friday on Strong Employment Data	MT

02/01/25	Avinger : Private Placement Form 8 K	PU
08/11/24	Avinger : Quarterly Report for Quarter Ending September 30, 2024 (Form 10-Q)	PU
08/11/24	Avinger : Reports Third Quarter 2024 Results Form 8 K	PU
07/11/24	Avinger: Q3 Earnings Snapshot	AQ
25/10/24	Avinger Releases Updated Data from IMAGE-BTK in Webinar Featuring Key Opinion Leaders in the Field of Vascular Intervention	AQ

Avinger, Inc. Share Price

Stocks

AVGR

US0537348775

Advanced Medical Equipment & Technology

Valuation: Avinger, Inc.

Latest news : Avinger, Inc.

Analysts' recommendations: Avinger, Inc.

Press Releases: Avinger, Inc.

Quotes and Performance

Course Extremes

Managers and Directors: Avinger, Inc.

Latest insider transactions

Medical Imaging Systems

Financials

Company Profile

Income Statement and Estimates

Date	Insider	Type	Main position	Quantity	% Market Cap.
23/01/25	Himanshu Patel	Sell	Founder	2,215	0.0669%
23/01/25	Nabeel Subainati	Sell	Chief Financial Officer	1,255	0.0379%
23/01/25	Jeffrey Soinski	Sell	Chief Executive Officer	3,690	0.1115%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
AVINGER, INC.	-20.74%	-.--%	-.--%	-95.61%	1.52M
SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.	-0.84%	+5.24%	-13.34%	-18.64%	14.02B
IRAY GROUP	+4.81%	-6.82%	+37.66%	-8.13%	3.9B
SONOSCAPE MEDICAL CORP.	+1.81%	+11.70%	-36.87%	-55.63%	1.27B
IRADIMED CORPORATION	-4.57%	-3.84%	+55.74%	+106.83%	1.16B
BEIJING WANDONG MEDICAL TECHNOLOGY CO.,LTD.	+1.98%	+9.99%	-35.09%	-44.14%	1.18B
SHANTOU INSTITUTE OF ULTRASONIC INSTRUMENT CO., LTD.	+1.35%	+5.63%	-43.85%	-	952M
CARERAY DIGITAL MEDICAL TECHNOLOGY CO., LTD.	+17.03%	+10.93%	+29.36%	+96.15%	500M
CAPSOVISION, INC.	-1.79%	+1.39%	+70.25%	-	329M
FISCHER MEDICAL VENTURES LIMITED	+0.36%	+2.02%	-59.87%	+221.90%	265M
Average	-0.06%	+3.36%	+0.40%	+25.34%	2.36B
Weighted average by Cap.	+0.66%	+2.16%	-3.55%	-8.31%

	2022	2023
Net sales	8.27M 7.19M 6.69M 6.15M 11.61M 790M 11.79M 78.9M 30.97M 393M 31.07M 30.39M 1.32B	7.65M 6.65M 6.19M 5.68M 10.73M 730M 10.9M 72.98M 28.64M 364M 28.74M 28.11M 1.22B
Net income	-17.62M -15.32M -14.26M -13.09M -24.72M -1.68B -25.11M -168M -65.97M -838M -66.18M -64.73M -2.81B	-18.32M -15.93M -14.82M -13.61M -25.7M -1.75B -26.1M -175M -68.58M -871M -68.8M -67.29M -2.92B
Net Debt	1.76M 1.53M 1.42M 1.3M 2.46M 168M 2.5M 16.75M 6.57M 83.45M 6.59M 6.45M 280M	10.12M 8.8M 8.19M 7.52M 14.2M 966M 14.42M 96.52M 37.88M 481M 38.01M 37.17M 1.61B

3 years	0.36	14
5 years	0.36	312
10 years	0.36	618,002.47